GlassScriptPhysician profile
Scott Gregory Shipley
NPI 1477510329
$7,699.41
in general payments reported to CMS, 2019-2025
27 companies · $1,238 in 2025
The $1,238 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,320 · 2020: $1,440 · 2021: $170 · 2022: $2,403 · 2023: $541 · 2024: $587 · 2025: $1,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,818 · Travel and Lodging: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,817.65 |
| Travel and Lodging | $548.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,875.17 | 2022-2025 | Inspire |
| Medical Device Business Services, INC. | $2,373.44 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $232.98 | 2019-2025 | Dupixent |
| Acclarent, INC | $188.98 | 2019 | |
| Ascendis Pharma Endocrinology INC | $120.83 | 2023 | |
| Aerin Medical INC. | $115.06 | 2019-2025 | |
| Glaxosmithkline, LLC. | $107.16 | 2022-2024 | Nucala |
| Intersect Ent, INC. | $79.24 | 2020-2021 | |
| Optinose US, INC. | $64.51 | 2021-2024 | |
| Genzyme Corporation | $59.35 | 2022-2025 | |
| Stryker Corporation | $55.83 | 2019-2023 | Scopis Ent, Xpress Ent Dilation System |
| Amgen INC. | $52.95 | 2021-2025 | Tavneos, Tezspire |
| Livanova USA, INC. | $52.77 | 2022 | |
| Zoll Respicardia, INC. | $46.81 | 2025 | Remede System |
| Medtronic, INC. | $39.18 | 2024-2025 | Novapak, Propel |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $39.17 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Abbvie INC. | $37.36 | 2020-2021 | |
| Aroa Biosurgery Incorporated | $21.09 | 2022 | |
| Kaleo, INC. | $19.81 | 2024 | Auvi-Q |
| Baxter Healthcare | $19.23 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $19.00 | 2022 | |
| Mallinckrodt Hospital Products INC. | $14.65 | 2023 | Acthar |
| Novo Nordisk INC | $14.42 | 2020 | |
| Ibsa Pharma INC. | $13.97 | 2020 | |
| Corcept Therapeutics | $13.33 | 2020 | |
| Itamar Medical INC | $11.57 | 2023 | Watchpatone |
| Merck Sharp & Dohme LLC | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Shipley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.